On December 6, 2007, Pietro Zorzetto of Padova, Itally was implanted with the SynCardia Total Artificial Heart. He remained on it for 1374 days (nearly 4 years) prior to his successful donor heart transplant on September 11, 2011.
Italian Man Surpasses 1,000 Days of Support
with SynCardia's Total Artificial Heart
54-Year-Old Man Enjoys Life at Home with Portable Driver While Waiting for a Matching Donor Heart
TUCSON, Ariz. – Oct. 12, 2010 – A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with the SynCardia temporary Total Artificial Heart while waiting for a matching donor heart.
"Life is a wonderful present that has to be respected," said Total Artificial Heart patient Pietro Zorzetto. "The Total Artificial Heart allowed me to recover to a very healthy physical condition. I really want to thank the SynCardia Total Artificial Heart for these unexpected 1,000 days of life."
Mr. Zorzetto was first admitted to Azienda Ospedaliera di Padova on Nov. 30, 2007, suffering from valvular cardiomyopathy. Two previous operations at a different hospital had failed to repair his failing heart. Less than a week later, on Dec. 6, 2007, Mr. Zorzetto made history when he became the first patient in Italy to be implanted with the SynCardia Total Artificial Heart.
"The Total Artificial Heart provides excellent cardiac output, which restored our patient to normal condition despite the fact he presented with severe multi-organ failure," said Prof. Gino Gerosa. "The Total Artificial Heart in combination with the portable driver has been extremely effective in providing the patient with a good quality of life with excellent exercise capacity."
Mr. Zorzetto has been enjoying life at home since Feb. 4, 2008, when he was discharged from the hospital using a portable driver to power his Total Artificial Heart. On a typical day, he walks 10 km and then exercises for an additional 30 minutes in his gym at home to stay in shape for a transplant.
CAUTION - The Freedom® portable driver is CE approved for commercial use in Europe and is undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
VIDEO: Watch Italian Total Artificial Heart patient Pietro Zorzetto ride his bicycle wearing the Freedom® portable driver in the Backpack. Video may take a few moments to download.
SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart.
Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.
More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.
SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by 190 patients, accounting for over 110 years of support.